We are pleased to provide 3 videotaped plenary sessions from the 43rd Annual CVAA Conference (April, 2018 in Toronto ON). They will be released in July 2018 (below), September 2018 (below) and November 2018.
IV Push Medications: Increasing Safety, Choosing Best Practice
Karen Laforet, MClSc, RN, VA-BC™, CVAA(C), IIWCC and Maureen Burger
Watch the presentation below and follow along with their handout here.
IV medications are clinically beneficial as they provide an immediate therapeutic effect. At the same time, the associated challenges contribute harm—for the patient and the health professional. Over the last few years, there has been much focus placed on IV infusion safety primary for nurses; not so much has been specific to IV push safety. Intravenous injection safety is not just a nursing issue—it is a systems-wide issue that few organizations address with any degree of standardization. This lack of organization-wide standardization has led to variability within organizations and among individual patient care units leading to significant risks for the patient, the health professional and the institution.
This presentation will identify the risks associated with IV push medications, with a specific focus on opioids. Examination of current evidence and consensus documents, results of a Canadian survey on opioid IV administration and standards for medication preparation will set the stage for a discussion on recommendations for safer adult IV push injection preparation and administration practices.
For Better or For Worse? Harm Reduction, Ethics and Patients who Use Substances with Vascular Access/Infusion Therapy Challenges
Jocelyn Hill, RN, MN, CVAA(c), VA-BC™
Watch the presentation below and follow along with the Power Point slides here.
There is a healthcare crisis happening that directly affects us as vascular access and infusion therapy clinicians and specialists. We care for many patients that have complex medical and personal situations which may include substance use. Our practice is guided by ethical responsibilities to all patients in our care – first and foremost, “to do no harm”. Harm reduction is one strategy that we should be more cognizant of as we interact, treat and care for patients who use substances.
Case studies will be presented based on experiences in a downtown, urban centre that is internationally recognized for spearheading innovation, research and evidence-based strategies while dealing with the opioid crisis.
The clinical situations these patients are dealing with often require some sort of vascular access and infusion therapy. Our role is key in the health and healing of all patients, but especially for those with a history and/or current use of substances that may or not be obvious. This session will bring theory of medical / nursing codes of ethics and harm reduction strategies to the forefront and discuss the impact on our clinical practice and personal feelings about challenging social issues.